Wearable injectors market is estimated to be over US$ 4.5 Bn in 2017. It is anticipated to grow at a CAGR of 12.1% from 2019 to 2030.
Increasing adoption of wearable injectors can be attributed to rising awareness, disposable incomes, and implementation of advanced drug delivery technologies. Moreover, rising prevalence of chronic disorders is anticipated to contribute substantially to the growth of the global wearable injectors market between 2019 and 2030.Educational establishments, namely Wyss Institute, have initiated partnership with KeepSmilin4Abbie Foundation, to develop wearable devices for both swift detection of anaphylaxis and automated treatment of the same by means of epinephrine delivery.
Major Players in the Wearable Injectors Market
The prominent players in the global wearable injectors market are Medtronic, Insulet Corporation, Tandem Diabetes Care, Amgen, Ypsomed, Becton Dickinson and Company, Enable Injections, Debiotech, Inc., Cellnovo, and Valeritas among others.
No comments:
Post a Comment